Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -13.367% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CCc1nnc(NC(=O)C(NC(=O)c2ccccc2Cl)C(C)C)s1
b.) CCC(=O)Nc1ccc(NC(=S)Nc2ccccc2)cc1
c.) O=C1OC(/C(=C\Nc2ccccc2)[N+](=O)[O-])c2ccccc21
Answer: b. CCC(=O)Nc1ccc(NC(=S)Nc2ccccc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccc(NC(=S)Nc2ccccc2)cc1
CCC(=O)Nc1ccc(NC(=S)Nc2ccccc2)cc1
N-[4-(phenylcarbamothioylamino)phenyl]propanamide